<i>Glycyrrhiza glabra</i>-Based Nasal Spray as a Novel Treatment for Chronic Rhinosinusitis with Nasal Polyps: Efficacy in Symptom Reduction and Epithelial-Mesenchymal Transition Modulation.

Int J Med Sci · 2026 · PMC12825008 · PMID 41583532

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Ear-related symptoms, however, such as ear dizziness and ear pain, did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

&lt;i&gt;Glycyrrhiza glabra&lt;/i&gt;-Based Nasal Spray as a Novel Treatment for Chronic Rhinosinusitis with Nasal Polyps: Efficacy in Symptom Reduction and Epithelial-Mesenchymal Transition Modulation.

The sentences

<i>Glycyrrhiza glabra</i>-Based Nasal Spray as a Novel Treatment for Chronic Rhinosinusitis with Nasal Polyps: Efficacy in Symptom Reduction and Epithelial-Mesenchymal Transition Modulation.